tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market

Avalo Therapeutics (AVTX) Income Statement

Compare
898 Followers

Avalo Therapeutics Income Statement

Last quarter (Q3 2024), Avalo Therapeutics's total revenue was $249.00K, an increase of 5.51% from the same quarter last year. In Q3, Avalo Therapeutics's net income was $23.04M. See Avalo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.92M$ 18.05M$ 5.40M$ 6.70M$ 6.75M
Gross Profit
$ 640.00K$ 14.62M$ 3.91M$ 6.40M$ -4.88M
Operating Expenses
$ 640.00K$ 52.06M$ 86.04M$ 53.69M$ 24.71M
Depreciation and Amortization
$ 158.00K$ 166.00K$ 1.66M$ 1.84M$ 1.46M
EBITDA
$ -27.95M$ -37.29M$ -80.50M$ -45.45M$ -17.36M
Operating Income
$ -23.44M$ -37.44M$ -82.13M$ -26.95M$ -17.39M
Other Income/Expenses
$ -8.09M$ -4.19M$ -2.41M$ 5.67M$ 12.26M
Pretax Income
$ -31.53M$ -41.63M$ -84.55M$ -67.18M$ -15.99M
Net Income
$ -31.54M$ -41.66M$ -84.35M$ -64.38M$ -16.27M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -113.58$ -1.06K$ -2.33K$ -2.52K$ -819.74
Diluted EPS
$ -113.58$ -1.06K$ -2.33K$ -2.52K$ -819.74
Weighted Average Shares Outstanding
277.73K 39.20K 36.19K 25.51K 19.85K
Weighted Average Shares Outstanding (Diluted)
277.73K 39.20K 36.19K 25.51K 19.85K
Currency in USD

Avalo Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis